Table 1 Characteristics and comparison between survivors and non-survivors determined by 30-day mortality.
Variable | All patients (n = 1838) | Survivors (n = 1279) | Non-survivors (n = 559) | p |
|---|---|---|---|---|
Age (years) | 65.79 (54.08–78.56) | 62.91 (51.79–74.83) | 74.49 (60.37–82.13) | < 0.001 |
Male | 942 (51.25%) | 657 (51.37%) | 285 (50.98%) | 0.879 |
Hospital mortality | 470 (25.57%) | 0 (0%) | 470 (84.08%) | < 0.001 |
ICU mortality | 368 (20.02%) | 0 (0%) | 368 (65.83%) | < 0.001 |
Length of ICU stay (days) | 3.21 (1.67–8.42) | 3.5 (1.71-10) | 2.88 (1.54–6.33) | < 0.001 |
Length of hospital stay (days) | 8.67 (4.5-15.58) | 10.5 (5.92–17.67) | 4.58 (1.71–9.75) | < 0.001 |
OASIS on admission | 33 (27–39) | 30 (25–36) | 39 (34–44) | < 0.001 |
SAPS II on admission | 33 (25–42) | 37 (22–37) | 42 (34–52) | < 0.001 |
GCS score on admission | 14 (11–15) | 14 (12–15) | 15 (7–15) | 0.385 |
White blood cell count on admission (k/uL) | 10.8 (8.2–14) | 10.3 (7.9–13.1) | 12.3 (9-15.7) | < 0.001 |
Blood platelet (k/µL) | 223 (178–281) | 226 (183–280) | 217 (163–282) | 0.004 |
Hemoglobin (g/dL) | 12.1 (10.8–13.3) | 12.2 (11.1–13.4) | 11.8 (10.2–13.1) | < 0.001 |
Elixhauser Comorbidity Index (SID30) | 8 (0–14) | 5 (0–13) | 8 (0–17) | < 0.001 |
Comorbidities | ||||
Chronic obstructive pulmonary disease | 10 (0.54%) | 5 (0.39%) | 5 (0.89%) | 0.183 |
Coronary heart disease | 190 (10.34%) | 123 (9.62%) | 67 (11.99%) | 0.125 |
Hypertension | 1074 (58.43%) | 743 (58.09%) | 331 (59.21%) | 0.654 |
Diabetes | 350 (19.04%) | 225 (17.59) | 125 (22.36%) | 0.017 |
